Literature DB >> 20146834

Functioning and disability levels in primary care out-patients with one or more anxiety disorders.

C D Sherbourne1, G Sullivan, M G Craske, P Roy-Byrne, D Golinelli, R D Rose, D A Chavira, A Bystritsky, M B Stein.   

Abstract

BACKGROUND: Anxiety disorders are the most prevalent mental health disorders and are associated with substantial disability and reduced well-being. It is unknown whether the relative impact of different anxiety disorders is due to the anxiety disorder itself or to the co-occurrence with other anxiety disorders. This study compared the functional impact of combinations of anxiety disorders in primary care out-patients.
METHOD: A total of 1004 patients with panic disorder (PD), generalized anxiety disorder (GAD), social anxiety disorder (SAD) or post-traumatic stress disorder (PTSD) provided data on their mental and physical functioning, and disability. Multivariate regressions compared functional levels for patients with different numbers and combinations of disorders.
RESULTS: Of the patients, 42% had one anxiety disorder only, 38% two, 16% three and 3% all four. There were few relative differences in functioning among patients with only one anxiety disorder, although those with SAD were most restricted in their work, social and home activities and those with GAD were the least impaired. Functioning levels tended to deteriorate as co-morbidity increased.
CONCLUSIONS: Of the four anxiety disorders examined, GAD appears to be the least disabling, although they all have more in common than in distinction when it comes to functional impairment. A focus on unique effects of specific anxiety disorders is inadequate, as it fails to address the more pervasive impairment associated with multiple anxiety disorders, which is the modal presentation in primary care.

Entities:  

Mesh:

Year:  2010        PMID: 20146834      PMCID: PMC2965310          DOI: 10.1017/S0033291710000176

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  39 in total

Review 1.  The comorbidity and mortality of panic disorder.

Authors:  R Noyes
Journal:  Psychiatr Med       Date:  1990

2.  Disability and quality of life in social phobia: epidemiologic findings.

Authors:  M B Stein; Y M Kean
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

3.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

4.  Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder.

Authors:  A O Massion; M G Warshaw; M B Keller
Journal:  Am J Psychiatry       Date:  1993-04       Impact factor: 18.112

5.  Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder.

Authors:  Christine Lochner; Modise Mogotsi; Pieter L du Toit; Debra Kaminer; Dana J Niehaus; Dan J Stein
Journal:  Psychopathology       Date:  2003 Sep-Oct       Impact factor: 1.944

6.  Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being.

Authors:  Gavin Andrews; Tim Slade; Cathy Issakidis
Journal:  Br J Psychiatry       Date:  2002-10       Impact factor: 9.319

Review 7.  Social anxiety disorder.

Authors:  Murray B Stein; Dan J Stein
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

8.  Quality of life in panic disorder.

Authors:  J S Markowitz; M M Weissman; R Ouellette; J D Lish; G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1989-11

Review 9.  The impairments caused by social phobia in the general population: implications for intervention.

Authors:  R C Kessler
Journal:  Acta Psychiatr Scand Suppl       Date:  2003

10.  Panic attacks in the community. Social morbidity and health care utilization.

Authors:  G L Klerman; M M Weissman; R Ouellette; J Johnson; S Greenwald
Journal:  JAMA       Date:  1991-02-13       Impact factor: 56.272

View more
  17 in total

Review 1.  Quality of life in panic disorder: looking beyond symptom remission.

Authors:  Julia Davidoff; Scott Christensen; David N Khalili; Jaidyn Nguyen; Waguih William IsHak
Journal:  Qual Life Res       Date:  2011-09-21       Impact factor: 4.147

2.  Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN).

Authors:  Laura Campbell-Sills; Emmanuel Espejo; Catherine R Ayers; Peter Roy-Byrne; Murray B Stein
Journal:  J Anxiety Disord       Date:  2015-09-18

3.  Childhood trauma and current psychological functioning in adults with social anxiety disorder.

Authors:  Janice R Kuo; Philippe R Goldin; Kelly Werner; Richard G Heimberg; James J Gross
Journal:  J Anxiety Disord       Date:  2010-11-26

4.  The correspondence of daily and retrospective PTSD reports among female victims of sexual assault.

Authors:  Kristin Naragon-Gainey; Tracy L Simpson; Sally A Moore; Alethea A Varra; Debra L Kaysen
Journal:  Psychol Assess       Date:  2012-05-21

Review 5.  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults.

Authors:  Hui Li; Jijun Wang; Chunbo Li; Zeping Xiao
Journal:  Cochrane Database Syst Rev       Date:  2014-09-17

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

7.  Single-subject anxiety treatment outcome prediction using functional neuroimaging.

Authors:  Tali M Ball; Murray B Stein; Holly J Ramsawh; Laura Campbell-Sills; Martin P Paulus
Journal:  Neuropsychopharmacology       Date:  2013-11-25       Impact factor: 7.853

8.  Implementation of the CALM intervention for anxiety disorders: a qualitative study.

Authors:  Geoffrey M Curran; Greer Sullivan; Peter Mendel; Michelle G Craske; Cathy D Sherbourne; Murray B Stein; Ashley McDaniel; Peter Roy-Byrne
Journal:  Implement Sci       Date:  2012-03-09       Impact factor: 7.327

9.  EEG microstate analysis in drug-naive patients with panic disorder.

Authors:  Mitsuru Kikuchi; Thomas Koenig; Toshio Munesue; Akira Hanaoka; Werner Strik; Thomas Dierks; Yoshifumi Koshino; Yoshio Minabe
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

10.  Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life.

Authors:  Robert Johansson; Per Carlbring; Åsa Heedman; Björn Paxling; Gerhard Andersson
Journal:  PeerJ       Date:  2013-07-09       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.